CD 20‐positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab

Yan, Min; Dong, Zhaoming; Zhao, Frank; R. Chauncey, Thomas; Deauna‐Limayo, Delva; Wang‐Rodriguez, Jessica; Liu, Dayu; Wang, Huan‐You; B. Pilz, Renate

doi:10.1111/ejh.12286

Public

CD 20‐positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab

Published in European Journal Of Haematology • Feb 17, 2014

Authors:

Min Yan

Zhaoming Dong

Frank Zhao

Abstract

As a distinct type of aggressive mature large B-cell lymphoma, plasmablastic lymphoma (PBL) poses diagnostic and treatment challenges. PBL is distinguished from other B-cell lymphomas by the presence of plasmacytic differentiation markers such as CD38, CD138, and MUM1. Clinically, PBLs from oral and...

Subject

Plasmablastic lymphoma

Bortezomib

Rituximab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!